Mavigen is a biotechnology company focused on developing innovative gene therapies and advanced biomanufacturing solutions. The company specializes in harnessing the power of genetic engineering to create therapies aimed at treating various diseases, with a particular emphasis on rare genetic disorders and conditions that currently lack effective treatment options. Mavigen leverages cutting-edge technologies and a strong scientific foundation to drive its research and development efforts, aiming to improve patient outcomes and enhance the quality of life for individuals affected by challenging health issues.